NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...

President Donald Trump's nominees to run the National Institutes of Health and the Food and Drug Administration are part of a group of scientists censored during the COVID-19 pandemic who are ...

Observational studies are critical tools in clinical research and public health response, but challenges arise in ensuring ...

Influenza A virus particles strategically adapt their shape-to become either spheres or larger filaments-to favor their ability to infect cells depending on environmental conditions, according to a ...

A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...